Tradestie Institutional Equity Comparison Engine

BCAX vs UPB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BCAX Overall Edge

BCAX Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bicara Therapeutics Inc. Common Stock (BCAX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BCAX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus UPB at N/M Forward P/E and -6116.0% operating margin (-42.2% YoY). In options structure, BCAX sits in BREAKDOWN (23rd %ile IV; Dealer Gamma Walls on Pro) against UPB sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BCAX N/M vs UPB N/M Fwd P/E
Growth & Margin Winner BCAX
Op Margin 0.0% vs -6116.0% ยท YoY +0.0% vs -42.2%
Momentum & Technical Winner BCAX
1Y -31.6% vs -90.8% ยท 52W Pos 8% vs 0%
Options & Structure Winner BCAX
BREAKDOWN (23rd %ile IV) vs BREAKDOWN (17th %ile IV)
BCAX NASDAQ
Bicara Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$9.75
-2.69% 1D
Market Cap $665.2M
1M Return -41.9%
1Y Return -31.63%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 58.0 Fund 66.0 Flow 68.0 Mom 64.0
UPB NASDAQ
Upstream Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.15
-22.66% 1D
Market Cap $152.4M
1M Return -22.1%
1Y Return -90.79%
Forward P/E N/M
Unified AI Score
43.6 / 100 HOLD
Tech 25.0 Fund 52.0 Flow 66.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BCAX -31.63% UPB -90.79% Spread: +59.16 pp (BCAX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BCAX TTM Op. Margin: 0.0% UPB TTM Op. Margin: -6116.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BCAX vs UPB. Trailing 12-month operating profitability (BCAX 0.0% vs UPB -6116.0%) and valuation multiples (BCAX N/M vs UPB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BCAX (5) vs UPB (2)
Institutional Metric BCAX UPB Criterion Row Winner
Market Capitalization Scale $665.2M $152.4M Larger Scale BCAX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -42.2% Higher Growth BCAX
Operating Margin (TTM) Profitability 0.0% -6116.0% Higher Margin BCAX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -54.2% -53.5% Higher ROE UPB
52-Week Range Position Momentum 8% ($8โ€“$31) 0% ($2โ€“$34) Stronger Trend BCAX
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 184% Vol 1.70ฮฒ ยท 120% Vol Lower Realized Risk UPB
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 43.6 / 100 (HOLD) Higher Composite BCAX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BCAX vs UPB Buy Guide
BCAX BREAKDOWN
93d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live BCAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UPB BREAKDOWN
152d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live UPB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BCAX nor UPB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.